Atlas Trials

Establishment of Individualized Immunotherapy Strategy and Platform Based on Changes of Intestinal Microbiota

Clinical trial NCT05065515 · UNKNOWN

Trial details

NCT number
NCT05065515
Sponsor
Xijing Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Gut Microbiota
Start date
2021-10-01
Primary completion
2023-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.